Physician profile
Ricardo Saiz
NPI 1821220963
$22,099.05
in general payments reported to CMS, 2019-2025
42 companies · $5,520 in 2025
The $5,520 reported for 2025 was more than what 98% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,404 · 2022: $3,783 · 2023: $4,171 · 2024: $4,220 · 2025: $5,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,700.72 |
| Education | $210.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,842.55 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,786.04 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Actelion Pharmaceuticals US, INC. | $2,069.53 | 2021-2025 | Uptravi, Opsumit |
| Mallinckrodt Hospital Products INC. | $1,886.67 | 2021-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,504.34 | 2021-2025 | Ofev, Spiriva, Jascayd |
| United Therapeutics Corporation | $1,478.11 | 2021-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $1,476.44 | 2021-2025 | Dupixent |
| Genzyme Corporation | $1,267.88 | 2021-2025 | |
| Insmed, INC. | $1,000.56 | 2021-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $899.51 | 2021-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $647.14 | 2021-2025 | Glassia, Cuvitru |
| Grifols USA, LLC | $565.99 | 2021-2025 | Prolastin-C Liquid |
| Baxter Healthcare | $460.98 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Ani Pharmaceuticals, INC. | $441.44 | 2022-2025 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $436.05 | 2025 | Yupelri |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $374.12 | 2025 | Ohtuvayre |
| Amgen INC. | $245.59 | 2022-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $205.13 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.89 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $182.67 | 2023-2025 | Winrevair |
| Inogen, INC. | $179.38 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Sanofi-Aventis U.S. LLC | $148.23 | 2021-2025 | |
| Advanced Respiratory, INC | $100.98 | 2021 | |
| Genentech USA, INC. | $97.28 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $65.70 | 2024-2025 | |
| Electromed, INC. | $55.20 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $54.41 | 2022-2023 | Xarelto |
| Pfizer INC. | $49.66 | 2021-2022 | |
| Gilead Sciences, INC. | $42.95 | 2021 | |
| Inari Medical, INC. | $39.14 | 2021 | |
| Optinose US, INC. | $34.34 | 2024-2025 | |
| Phadia US INC. | $34.14 | 2022-2023 | Immunocap |
| Fisher & Paykel Healthcare INC | $33.05 | 2024 | Fisher & Paykel Healthcare |
| Csl Behring | $30.03 | 2024 | Hizentra |
| Sanofi Pasteur INC. | $27.44 | 2025 | |
| Pulmonx Corporation | $24.75 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Philips North America LLC | $23.89 | 2021 | |
| Nabriva Therapeutics, Plc | $20.94 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $19.58 | 2021 | |
| Inspire Medical Systems, INC. | $18.45 | 2025 | Inspire |
| Octapharma USA, INC. | $17.74 | 2021 | |
| Vapotherm INC | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Saiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.